Cyclomedica News

Lung Imaging and COVID-19 Impact

22nd Dec 2020

Continue Reading

Technegas® NDA pending US FDA review

16th Dec 2020

Continue Reading

USFDA Approval to File Received for Technegas™

27th May 2020

Continue Reading

Technegas™ approved in Russia

26th May 2020

Continue Reading

Clinical research opportunity in COVID-19

4th May 2020

Continue Reading

Cyclomedica Lodges NDA for Technegas™ with the USFDA

30th Mar 2020

Continue Reading

Technegas™ is not an aerosol generating procedure

23rd Mar 2020

Continue Reading

Technegas™ and Covid-19

20th Mar 2020

Continue Reading

Visit us at booth #878 – SNMMI 2019 Annual Meeting

19th Jun 2019

Continue Reading

Cyclomedica will exhibit at the German Annual Meeting of Nuclear Medicine

1st Mar 2019

Continue Reading

Cyclomedica will exhibit at the EANM 2019 congress

1st Mar 2019

Continue Reading

New Guidelines from the CANM

18th Jan 2019

Continue Reading

Cyclopharm (ASX:CYC) results of US FDA meeting

29th Oct 2018

Continue Reading

Cyclopharm (ASX:CYC) radiopharmaceutical leader

8th Oct 2018

Continue Reading

Our 4th million Patient Administration Set has been manufactured

31st May 2018

Continue Reading

Copyright © Cyclomedica Europe 2021 | Last Updated: March 8, 2019 Privacy Policy